XML 40 R31.htm IDEA: XBRL DOCUMENT v3.23.1
Financial Instruments (Narrative) (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2023
USD ($)
Mar. 31, 2022
USD ($)
Sep. 02, 2020
USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Increase (decrease) in fair value of contingent consideration $ 4,800 $ (1,800)  
Ascyrus Medical LLC      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Percentage of outstanding equity acquired     100.00%
Maximum amount of future consideration payment     $ 100,000
Increase (decrease) in fair value of contingent consideration $ (4,800) $ 1,800  
Ascyrus Medical LLC | Measurement Input, Discount Rate      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Contingent consideration, measurement input 0.13